Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
GLAXO Stock Chart & Stats
₹2474.85
-₹2.55(-0.12%)
At close: 4:00 PM EST
₹2474.85
-₹2.55(-0.12%)
Day’s Range― - ―
52-Week Range₹1,924.30 - ₹3,515.95
Previous CloseN/A
Volume25.42K
Average Volume (3M)1.83K
Market Cap
₹450.87B
Enterprise Value₹462.29B
Total Cash (Recent Filing)₹24.98B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)47.4
Beta0.75
Next Earnings
Feb 09, 2026EPS EstimateN/A
Last Dividend Ex-Date
May 30, 2025Dividend Yield2.18%
Share Statistics
EPS (TTM)15.00
Shares Outstanding169,406,040
10 Day Avg. Volume1,472
30 Day Avg. Volume1,831
Financial Highlights & Ratios
PEG Ratio0.89
Price to Book (P/B)24.29
Price to Sales (P/S)12.64
P/FCF Ratio37.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GlaxoSmithKline Pharmaceuticals Limited News
GLAXO FAQ
What was GlaxoSmithKline Pharmaceuticals Limited’s price range in the past 12 months?
GlaxoSmithKline Pharmaceuticals Limited lowest stock price was ₹1924.30 and its highest was ₹3515.95 in the past 12 months.
What is GlaxoSmithKline Pharmaceuticals Limited’s market cap?
GlaxoSmithKline Pharmaceuticals Limited’s market cap is ₹450.87B.
When is GlaxoSmithKline Pharmaceuticals Limited’s upcoming earnings report date?
GlaxoSmithKline Pharmaceuticals Limited’s upcoming earnings report date is Feb 09, 2026 which is in 74 days.
How were GlaxoSmithKline Pharmaceuticals Limited’s earnings last quarter?
GlaxoSmithKline Pharmaceuticals Limited released its earnings results on Nov 06, 2025. The company reported ₹15 earnings per share for the quarter, beating the consensus estimate of N/A by ₹15.
Is GlaxoSmithKline Pharmaceuticals Limited overvalued?
According to Wall Street analysts GlaxoSmithKline Pharmaceuticals Limited’s price is currently Overvalued.
Does GlaxoSmithKline Pharmaceuticals Limited pay dividends?
GlaxoSmithKline Pharmaceuticals Limited pays a Annually dividend of ₹42 which represents an annual dividend yield of 2.18%. See more information on GlaxoSmithKline Pharmaceuticals Limited dividends here
What is GlaxoSmithKline Pharmaceuticals Limited’s EPS estimate?
GlaxoSmithKline Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GlaxoSmithKline Pharmaceuticals Limited have?
GlaxoSmithKline Pharmaceuticals Limited has 169,406,040 shares outstanding.
What happened to GlaxoSmithKline Pharmaceuticals Limited’s price movement after its last earnings report?
GlaxoSmithKline Pharmaceuticals Limited reported an EPS of ₹15 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.209%.
Which hedge fund is a major shareholder of GlaxoSmithKline Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in IN:GLAXO
Company Description
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is a global healthcare company focused on the research, development, and manufacturing of pharmaceuticals, vaccines, and consumer healthcare products. With a diverse portfolio that includes treatments for respiratory, HIV, oncology, and immunology conditions, GLAXO aims to improve health and well-being across various populations. The company operates in three main sectors: Pharmaceuticals, Vaccines, and Consumer Healthcare, leveraging scientific innovation to deliver effective solutions to patients and consumers worldwide.
Technical Analysis
Cipla Ltd
―
Dr. Reddy's Laboratories Ltd.
―
Lupin Limited
―
Sun Pharmaceutical Industries Limited
―
Torrent Pharmaceuticals Ltd
―